These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7813222)

  • 21. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD.
    Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T
    Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of nomegestrol acetate subdermal contraceptive implant, uniplant, during lactation.
    Abdel-Aleem H; Abol-Oyoun el-S M; Shaaban MM; el-Saeed M; Shoukry M; Makhlouf A; Salem HT
    Contraception; 1996 Nov; 54(5):281-6. PubMed ID: 8934061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal trends of copper-bearing intrauterine device discontinuation: a population-based birth-cohort study of contraceptive use among rural married women in China.
    Zhou J; Tan X; Song X; Zhang K; Fang J; Peng L; Qi W; Nie Z; Li M; Deng R; Yan C
    Asia Pac J Public Health; 2015 Mar; 27(2):NP2433-42. PubMed ID: 24408865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of IUDs in developing countries: a comparative study.
    Farr G; Burdan A
    Netw Res Triangle Park N C; 1991 Sep; 12(2):6-8, 12. PubMed ID: 12284280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
    Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
    Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparative study of three types of IUD].
    Lai KR; Chen QB
    Shengzhi Yu Biyun; 1991 Nov; 11(4):46-54. PubMed ID: 12284922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age.
    Bahamondes L; Faundes A; Sobreira-Lima B; Lui-Filho JF; Pecci P; Matera S
    Contraception; 2005 Nov; 72(5):337-41. PubMed ID: 16246658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrauterine contraception.
    Reinprayoon D
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):527-30. PubMed ID: 1324024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the TCu 380Ag and the Multiload Cu375.
    Cole LP; Potts DM; Aranda C; Behlilovic B; Etman ES; Moreno J; Randic L
    Fertil Steril; 1985 Feb; 43(2):214-7. PubMed ID: 3881295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary report on a postpartum CuT 200 study, Santiago, Chile.
    Lavin P; Waszak C; Bravo C
    Int J Gynaecol Obstet; 1983 Feb; 21(1):71-5. PubMed ID: 6133798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menstrual problems and side effects associated with long-term TCu 380A IUD use in perimenopausal women.
    Reinprayoon D; Taneepanichskul S
    Contraception; 1998 Jun; 57(6):417-9. PubMed ID: 9693403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
    Pardthaisong T; Gray RH; McDaniel EB
    Lancet; 1980 Mar; 1(8167):509-12. PubMed ID: 6102234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
    Newton J; Szontagh F; Lebech P; Rowe P
    Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choice of contraceptive modality by women in Norway.
    Skjeldestad FE
    Acta Obstet Gynecol Scand; 1994 Jan; 73(1):48-52. PubMed ID: 8304025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four years of experience with the TCu 380A intrauterine contraceptive device.
    Sivin I; Tatum HJ
    Fertil Steril; 1981 Aug; 36(2):159-63. PubMed ID: 7262334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of IUDs: a review.
    Sivin I; Schmidt F
    Contraception; 1987 Jul; 36(1):55-84. PubMed ID: 3311626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between two techniques used in immediate postplacental insertion of TCu 380A intrauterine device: 36-month follow-up.
    Xu J; Yang X; Gu X; Xu S; Zhou X; Chen Y; Xiao Z; Zhuang L
    Reprod Contracept; 1999; 10(3):156-62. PubMed ID: 12349462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-year clinical experience with FlexiGard.
    Batar I
    Contraception; 1992 Oct; 46(4):307-12. PubMed ID: 1486769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.